3种抗生素治疗呼吸道感染的成本-效果分析

Three antibiotic treatment of respiratory tract infection Cost-Effectiveness Analysis

目的呼吸道感染以下呼吸道感染为主要的常见病,多发病包括急性气管-支气管炎、慢性支气管炎急性发作、支气管扩张合并感染、肺胀肿胀胸、医院获得性肺炎、社区获得性肺炎等肺实质感染,目前治疗常用β内酰胺类抗生素。方法我们通过回顾性分析2009年9月份~2010年6月份呼吸内科常用三种抗生素治疗方案进行成本-效果分析。结果以期寻找既能得到理想的治疗方案又能得到经济效益较佳的治疗方案,同时为临床合理用药提供依据。结论 3种治疗方案的临床疗效比较,差异无统计学意义（P〉0.05）,但费用最低的是头孢米诺钠组,因此,从实验结果分析得出,头孢米诺钠是治疗下呼吸道感染的最佳方案。

Objective Respiratory tract infection following respiratory tract infections are the main common disease, including acute tracheo-bronchitis, chronic bronchitis, acute exacerbation, bronchiectasis with infection, community-acquired pneumonia, hospital-acquired pneumonia, lung swelling swelling of the chest The lung parenchyma infection, commonly used 13 lactam antibiotics for treatment. Methods Through retrospective analysis of Respiratory Medicine in September 2009 to June 2010 of three antibiotics commonly used treatment options for cost - effectiveness analysis, Results In order to find not only the ideal treatment program while the economic benefits of better treatment options.At the same time provide the basis for clinical medication. Concluson The clinical efficacy of the conclusions of three kinds of treatment programs close, the difference was not statistically significant （P〉 0.05）, cefminox sodium group the lowest cost from the experimental effect of the efficacy analysis, cefminox sodium treatment of lower respiratory tract infections, good program.